4D Molecular Therapeutics
Price & Volume
Stats
See more52W Range | $3.92-$36.25 |
Market Cap | $188.4M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $37,000 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$141.2M |
Diluted EPS | -$2.98 |
News
See moreYahoo Finance • last year
4D Molecular Therapeutics Inc CEO David Kirn Sells 102,303 Shares
Yahoo Finance • last year
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Cystic Fibrosis at 2023 NACFC
About
CEO | Dr. David H. Kirn M.D. |
Address | 5858 Horton Street, EmeryVille, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
